| Product Code: ETC6743907 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Gastroesophageal Reflux Disease Therapeutics Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Gastroesophageal Reflux Disease Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 China Gastroesophageal Reflux Disease Therapeutics Market - Industry Life Cycle |
3.4 China Gastroesophageal Reflux Disease Therapeutics Market - Porter's Five Forces |
3.5 China Gastroesophageal Reflux Disease Therapeutics Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
4 China Gastroesophageal Reflux Disease Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastroesophageal reflux disease (GERD) in China |
4.2.2 Growing awareness and diagnosis of GERD in the Chinese population |
4.2.3 Rising healthcare expenditure and improved access to healthcare services in China |
4.3 Market Restraints |
4.3.1 High cost of GERD therapeutics and treatment options |
4.3.2 Limited availability and access to advanced GERD treatment options in rural areas of China |
4.3.3 Stringent regulatory requirements for approval of new therapeutics in China |
5 China Gastroesophageal Reflux Disease Therapeutics Market Trends |
6 China Gastroesophageal Reflux Disease Therapeutics Market, By Types |
6.1 China Gastroesophageal Reflux Disease Therapeutics Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 China Gastroesophageal Reflux Disease Therapeutics Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 China Gastroesophageal Reflux Disease Therapeutics Market Revenues & Volume, By Antacids, 2021- 2031F |
6.1.4 China Gastroesophageal Reflux Disease Therapeutics Market Revenues & Volume, By H2 Receptor Blockers, 2021- 2031F |
6.1.5 China Gastroesophageal Reflux Disease Therapeutics Market Revenues & Volume, By Proton Pump Inhibitors (PPIs), 2021- 2031F |
6.1.6 China Gastroesophageal Reflux Disease Therapeutics Market Revenues & Volume, By Pro-kinetic agents, 2021- 2031F |
7 China Gastroesophageal Reflux Disease Therapeutics Market Import-Export Trade Statistics |
7.1 China Gastroesophageal Reflux Disease Therapeutics Market Export to Major Countries |
7.2 China Gastroesophageal Reflux Disease Therapeutics Market Imports from Major Countries |
8 China Gastroesophageal Reflux Disease Therapeutics Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed GERD medications |
8.2 Rate of adoption of minimally invasive GERD treatment procedures in China |
8.3 Percentage of healthcare providers trained in diagnosing and managing GERD |
9 China Gastroesophageal Reflux Disease Therapeutics Market - Opportunity Assessment |
9.1 China Gastroesophageal Reflux Disease Therapeutics Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10 China Gastroesophageal Reflux Disease Therapeutics Market - Competitive Landscape |
10.1 China Gastroesophageal Reflux Disease Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 China Gastroesophageal Reflux Disease Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here